{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:59:48Z","timestamp":1794887988679,"version":"4.9.1"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1163235"],"award-info":[{"award-number":["APP1163235"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1148700"],"award-info":[{"award-number":["APP1148700"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1148700"],"award-info":[{"award-number":["1148700"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1163235"],"award-info":[{"award-number":["1163235"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ijpddr.2022.11.001","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T07:54:57Z","timestamp":1668153297000},"page":"135-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Current and emerging target identification methods for novel antimalarials"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9210-3095","authenticated-orcid":false,"given":"Matthew P.","family":"Challis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8727-7392","authenticated-orcid":false,"given":"Shane M.","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Creek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2022.11.001_bib1","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.1128\/AAC.01224-16","article-title":"Metabolomic profiling of the malaria Box reveals antimalarial target pathways","volume":"60","author":"Allman","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.chembiol.2003.09.002","article-title":"The process of structure-based drug design","volume":"10","author":"Anderson","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/1475-2875-11-316","article-title":"The global pipeline of new medicines for the control and elimination of malaria","volume":"11","author":"Anthony","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s42003-020-0795-6","article-title":"An isothermal shift assay for proteome scale drug-target identification","volume":"3","author":"Ball","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14451","article-title":"A novel multiple-stage antimalarial agent that inhibits protein synthesis","volume":"522","author":"Baragana","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nchembio.2185","article-title":"Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat","volume":"12","author":"Becher","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1074\/mcp.RA119.001797","article-title":"Multi-omic characterization of the mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum","volume":"19","author":"Birrell","year":"2020","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm.4381","article-title":"Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic","volume":"23","author":"Blasco","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib10","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1074\/mcp.TIR119.001481","article-title":"Nonparametric analysis of thermal proteome profiles reveals novel drug-binding proteins","volume":"18","author":"Childs","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/infdis\/jiz534","article-title":"A novel antiparasitic compound kills ring-stage Plasmodium falciparum and retains activity against artemisinin-resistant parasites","volume":"221","author":"Clements","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib12","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1021\/jm200592f","article-title":"Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential","volume":"54","author":"Coteron","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/1178636118808529","article-title":"Exploration of the Plasmodium falciparum resistome and druggable genome reveals new mechanisms of drug resistance and antimalarial targets","volume":"11","author":"Cowell","year":"2018","journal-title":"Microbiol. Insights"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1126\/science.aan4472","article-title":"Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics","volume":"359","author":"Cowell","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13073-019-0673-3","article-title":"Advances in omics-based methods to identify novel targets for malaria and other parasitic protozoan infections","volume":"11","author":"Cowell","year":"2019","journal-title":"Genome Med."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13073-019-0673-3","article-title":"Advances in omics-based methods to identify novel targets for malaria and other parasitic protozoan infections","volume":"11","author":"Cowell","year":"2019","journal-title":"Genome Med."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1017\/S0031182013000814","article-title":"Determination of antiprotozoal drug mechanisms by metabolomics approaches","volume":"141","author":"Creek","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib18","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1128\/AAC.01226-16","article-title":"Metabolomics-based screening of the malaria Box reveals both novel and established mechanisms of action","volume":"60","author":"Creek","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1046\/j.1365-3156.2001.00819.x","article-title":"History and importance of antimalarial drug resistance","volume":"6","author":"D'Alessandro","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib20","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1038\/s41467-018-05777-2","article-title":"A high throughput screen for next-generation leads targeting malaria parasite transmission","volume":"9","author":"Delves","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/srep37502","article-title":"Identification of inhibitors that dually target the new permeability pathway and dihydroorotate dehydrogenase in the blood stage of Plasmodium falciparum","volume":"6","author":"Dickerman","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib23","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41598-021-81486-z","article-title":"Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites","volume":"11","author":"Dorjsuren","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1042\/BJ20140240","article-title":"From crystal to compound: structure-based antimalarial drug discovery","volume":"461","author":"Drinkwater","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.pt.2021.04.006","article-title":"Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials","volume":"37","author":"Duffey","year":"2021","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11306-012-0434-4","article-title":"Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics","volume":"9","author":"Dunn","year":"2012","journal-title":"Metabolomics"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib27","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/s41596-020-0310-z","article-title":"Cellular thermal shift assay for the identification of drug-target interactions in the Plasmodium falciparum proteome","volume":"15","author":"Dziekan","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau3174","article-title":"Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay","volume":"11","author":"Dziekan","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.chom.2020.02.005","article-title":"Dual plasmepsin-targeting antimalarial agents disrupt multiple stages of the malaria parasite life cycle","volume":"27","author":"Favuzza","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib30","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/nbt.2999","article-title":"Global analysis of protein structural changes in complex proteomes","volume":"32","author":"Feng","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib31","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.1021\/jm400325j","article-title":"Using genetic methods to define the targets of compounds with antimalarial activity","volume":"56","author":"Flannery","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1021\/cb500616x","article-title":"Mutations in the P-type cation-transporter ATPase 4, PfATP4, mediate resistance to both aminopyrazole and spiroindolone antimalarials","volume":"10","author":"Flannery","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib33","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/nprot.2015.101","article-title":"Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry","volume":"10","author":"Franken","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib34","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0006-2952(92)90213-3","article-title":"Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80)","volume":"43","author":"Fry","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib36","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008485","article-title":"System-wide biochemical analysis reveals ozonide antimalarials initially act by disrupting Plasmodium falciparum haemoglobin digestion","volume":"16","author":"Giannangelo","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib38","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrm2208","article-title":"Analysis of protein complexes using mass spectrometry","volume":"8","author":"Gingras","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.chembiol.2017.11.010","article-title":"Specific inhibition of the bifunctional farnesyl\/geranylgeranyl diphosphate Synthase in malaria parasites via a new small-molecule binding site","volume":"25","author":"Gisselberg","year":"2018","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib40","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1039\/C0CS00004C","article-title":"Activity-based probes: discovering new biology and new drug targets","volume":"40","author":"Heal","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib41","first-page":"89","article-title":"Artemisinin-based antimalarial drug therapy: molecular pharmacology and evolving resistance","volume":"4","author":"Heller","year":"2019","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib42","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1021\/acschembio.0c00369","article-title":"Identifying the target of an antiparasitic compound in Toxoplasma using thermal proteome profiling","volume":"15","author":"Herneisen","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib43","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/dnares\/dsu009","article-title":"Generation of rodent malaria parasites with a high mutation rate by destructing proofreading activity of DNA polymerase \u03b4","volume":"21","author":"Honma","year":"2014","journal-title":"DNA Res."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pt.2016.04.014","article-title":"Phenotypic screens in antimalarial drug discovery","volume":"32","author":"Hovlid","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib45","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1073\/pnas.1600459113","article-title":"Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites Plasmodium falciparum 3D7","volume":"113","author":"Ismail","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib46","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1126\/science.1167983","article-title":"Comprehensive characterization of genes required for protein folding in the endoplasmic reticulum","volume":"323","author":"Jonikas","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib47","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1021\/acsinfecdis.9b00264","article-title":"Stochastic protein alkylation by antimalarial peroxides","volume":"5","author":"Jourdan","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib48","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1039\/C3MD00276D","article-title":"Affinity-based target identification for bioactive small molecules","volume":"5","author":"Kawatani","year":"2014","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib50","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1021\/acsptsci.0c00078","article-title":"Torin 2 derivative, NCATS-SM3710, has potent multistage antimalarial activity through inhibition of P. falciparum phosphatidylinositol 4-kinase (PfPI4KIII\u03b2)","volume":"3","author":"Krishnan","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib51","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/AAC.02727-13","article-title":"KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission","volume":"58","author":"Kuhen","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00696-16","article-title":"Mutations in the Plasmodium falciparum cyclic amine resistance Locus (PfCARL) confer multidrug resistance","volume":"7","author":"LaMonte","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib53","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41467-020-15440-4","article-title":"Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway","volume":"11","author":"LaMonte","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib54","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1021\/acs.jmedchem.0c02022","article-title":"Novel antimalarial tetrazoles and amides active against the hemoglobin degradation pathway in Plasmodium falciparum","volume":"64","author":"Lawong","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib55","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1073\/pnas.0910040106","article-title":"Target identification using drug affinity responsive target stability (DARTS)","volume":"106","author":"Lomenick","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib56","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4269\/ajtmh.1996.54.62","article-title":"Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand","volume":"54","author":"Looareesuwan","year":"1996","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib57","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1073\/pnas.1913525117","article-title":"Plasmodium chaperonin TRiC\/CCT identified as a target of the antihistamine clemastine using parallel chemoproteomic strategy","volume":"117","author":"Lu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib58","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/acsinfecdis.7b00276","article-title":"Using in vitro evolution and whole genome analysis to discover next generation targets for antimalarial drug discovery","volume":"4","author":"Luth","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib59","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1021\/acsinfecdis.6b00025","article-title":"Plasmodium falciparum cyclic amine resistance Locus (PfCARL), a resistance mechanism for two distinct compound classes","volume":"2","author":"Magistrado","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib60","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Martinez Molina","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib61","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.1038\/s41598-018-27834-y","article-title":"A widely-applicable high-throughput cellular thermal shift assay (CETSA) using split Nano Luciferase","volume":"8","author":"Martinez","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib62","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3390\/molecules25051030","article-title":"Protein X-ray crystallography and drug discovery","volume":"25","author":"Maveyraud","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/2472555217732014","article-title":"A high-throughput dose-response cellular thermal shift assay for rapid screening of drug target engagement in living cells, exemplified using SMYD3 and Ido1","volume":"23","author":"McNulty","year":"2018","journal-title":"SLAS Discov"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib64","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.1211936","article-title":"Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery","volume":"334","author":"Meister","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib65","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nmeth.2557","article-title":"The CRAPome: a contaminant repository for affinity purification-mass spectrometry data","volume":"10","author":"Mellacheruvu","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib66","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1021\/acsinfecdis.2c00364","article-title":"Toolkit of approaches to support target-focused drug discovery for Plasmodium falciparum lysyl tRNA synthetase","volume":"8","author":"Milne","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib67","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Molina","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib68","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1015-1015","article-title":"Landmark green light for Mosquirix malaria vaccine","volume":"33","author":"Morrison","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib69","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/molbev\/msm087","article-title":"Parallel evolution of adaptive mutations in Plasmodium falciparum mitochondrial DNA during atovaquone-proguanil treatment","volume":"24","author":"Musset","year":"2007","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib70","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/jac\/dkp449","article-title":"In vitro selection of Plasmodium falciparum drug-resistant parasite lines","volume":"65","author":"Nzila","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib71","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.pt.2021.02.007","article-title":"Genomic and genetic approaches to studying antimalarial drug resistance and Plasmodium biology","volume":"37","author":"Okombo","year":"2021","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9735","article-title":"Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase","volume":"9","author":"Paquet","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113918","article-title":"A chemical proteomics approach for the search of pharmacological targets of the antimalarial clinical candidate albitiazolium in Plasmodium falciparum using photocrosslinking and click chemistry","volume":"9","author":"Penarete-Vargas","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib74","article-title":"Malaria","volume":"3","author":"Phillips","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib75","doi-asserted-by":"crossref","first-page":"296ra111","DOI":"10.1126\/scitranslmed.aaa6645","article-title":"A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria","volume":"7","author":"Phillips","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib76","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1038\/s41467-020-18071-x","article-title":"A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes","volume":"11","author":"Piazza","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib77","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cell.2017.12.006","article-title":"A map of protein-metabolite interactions reveals principles of chemical communication","volume":"172","author":"Piazza","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib78","first-page":"CD000363","article-title":"Insecticide-treated nets for preventing malaria","volume":"11","author":"Pryce","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib79","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1042\/BST20160025","article-title":"Membrane proteins: always an insoluble problem?","volume":"44","author":"Rawlings","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib80","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41467-020-20629-8","article-title":"Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box","volume":"12","author":"Reader","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib81","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1193225","article-title":"Spiroindolones, a potent compound class for the treatment of malaria","volume":"329","author":"Rottmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/science.1255784","article-title":"Tracking cancer drugs in living cells by thermal profiling of the proteome","volume":"346","author":"Savitski","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib83","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11306-009-0168-0","article-title":"Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research","volume":"5","author":"Scalbert","year":"2009","journal-title":"Metabolomics"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib84","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jconrel.2015.09.048","article-title":"Surface plasmon resonance as a high throughput method to evaluate specific and non-specific binding of nanotherapeutics","volume":"219","author":"Schneider","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib85","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1038\/nprot.2017.100","article-title":"Measuring protein structural changes on a proteome-wide scale using limited proteolysis-coupled mass spectrometry","volume":"12","author":"Schopper","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib86","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41598-017-18650-x","article-title":"Determining direct binders of the androgen receptor using a high-throughput cellular thermal shift assay","volume":"8","author":"Shaw","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib87","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/acsinfecdis.1c00550","article-title":"Peroxide antimalarial drugs target redox homeostasis in Plasmodium falciparum infected red blood cells","volume":"8","author":"Siddiqui","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib88","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.chembiol.2004.03.012","article-title":"Profiling enzyme activities in vivo using click chemistry methods","volume":"11","author":"Speers","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib89","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpddr.2015.07.001","article-title":"The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs","volume":"5","author":"Spillman","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib90","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nprot.2012.146","article-title":"Thermodynamic analysis of protein-ligand binding interactions in complex biological mixtures using the stability of proteins from rates of oxidation","volume":"8","author":"Strickland","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib91","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.cbpa.2013.06.005","article-title":"Target identification of biologically active small molecules via in situ methods","volume":"17","author":"Su","year":"2013","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib92","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jasms.2007.03.028","article-title":"Developing limited proteolysis and mass spectrometry for the characterization of ribosome topography","volume":"18","author":"Suh","year":"2007","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib93","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acsinfecdis.5b00143","article-title":"High-throughput luciferase-based assay for the discovery of therapeutics that prevent malaria","volume":"2","author":"Swann","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib94","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of anti-malarial medicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib95","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1074\/jbc.M807085200","article-title":"Co-inhibition of Plasmodium falciparum S-adenosylmethionine decarboxylase\/ornithine decarboxylase reveals perturbation-specific compensatory mechanisms by transcriptome, proteome, and metabolome analyses","volume":"284","author":"van Brummelen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib96","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.chembiol.2020.04.001","article-title":"Inhibition of resistance-refractory P. falciparum kinase PKG delivers prophylactic, blood stage, and transmission-blocking antiplasmodial activity","volume":"27","author":"Vanaerschot","year":"2020","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib97","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/protein\/gzz018","article-title":"Kinetic trapping in protein folding","volume":"32","author":"Varela","year":"2019","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10111","article-title":"Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib99","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1021\/acsinfecdis.8b00211","article-title":"Identification and mechanistic understanding of dihydroorotate dehydrogenase point mutations in Plasmodium falciparum that confer in vitro resistance to the clinical candidate DSM265","volume":"5","author":"White","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib100","series-title":"World Malaria Report 2021","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.ijpddr.2022.11.001_bib101","doi-asserted-by":"crossref","first-page":"10053","DOI":"10.1021\/acs.jmedchem.8b01161","article-title":"Target validation and identification of novel boronate inhibitors of the Plasmodium falciparum proteasome","volume":"61","author":"Xie","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib102","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.pt.2021.01.009","article-title":"MalDA, accelerating malaria drug discovery","volume":"37","author":"Yang","year":"2021","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2022.11.001_bib103","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.chembiol.2020.01.001","article-title":"The antimalarial natural product Salinipostin A identifies essential \u03b1\/\u03b2 serine hydrolases involved in lipid metabolism in P. falciparum parasites","volume":"27","author":"Yoo","year":"2020","journal-title":"Cell Chem Biol"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320722000288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320722000288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:39:59Z","timestamp":1778845199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320722000288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":103,"alternative-id":["S2211320722000288"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2022.11.001","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and emerging target identification methods for novel antimalarials","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}